-
Here’s What Dragged Eli Lilly and Company (LLY) Down in Q2
26 Sep 2025 21:33 GMT
… highlighted stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a … guidance, not factoring in any benefit from recent dollar weakness, setting … 's book of Pharmacy Benefit Management (PBM) business, triggering investor …
-
Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs
26 Sep 2025 15:28 GMT
… the U.S. This is benefiting Eli Lilly And Co (NYSE: LLY) and other … the U.S. This is benefiting PACCAR Inc (NASDAQ: PCAR … tariffs on cabinets. This is benefiting American Woodmark Corp (NASDAQ: … 100% tariffs. This news is benefiting Intel Corp (NASDAQ: INTC) …
-
Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production
25 Sep 2025 10:56 GMT
… According to Billionaires. Eli Lilly and Company is one of them. Eli Lilly and Company (NYSE:LLY) tops … Monoclonal Antibody Production On pricing, Eli Lilly and Company (NYSE:LLY) introduced a … stock that also stands to benefit significantly from Trump-era …
-
Alzheimer’s Drug Franchise Decides Eli Lilly And Co.’s (LLY) Performance
24 Sep 2025 00:24 GMT
… highlighted stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is … Was Jim Cramer Right About Eli Lilly and Company (LLY)? Eli Lilly and Company (NYSE:LLY) is in … stock that also stands to benefit significantly from Trump-era …
-
<![CDATA[Tirzepatide Is A ‘Ray of Hope’ for Patients with OSA: Referral Uptick, Who Benefits]]>
26 Sep 2025 02:03 GMT
Ever since the US Food & Drug Administration (FDA) approved tirzepatide (Zepbound) for obstructive sleep apnea (OSA) last December, there has been an increase in OSA referrals.1
Tripeptide’s FDA approval, announced by Eli Lilly and Company on December …
-
European Commission Approves Eli Lilly’s Kisunla for Early Alzheimer’s Disease
26 Sep 2025 19:32 GMT
Eli Lilly and Company announced that the European Commission … , highlighted that Kisunla showed meaningful benefits by significantly slowing cognitive and …
-
<![CDATA[Pirtobrutinib Offers Potential Second-Line Treatment in CLL]]>
26 Sep 2025 19:14 GMT
… some populations that might greatly benefit from pirtobrutinib in the frontline … suggested might get the most benefit from pirtobrutinib in the … small-lymphocytic
Jaypirca. Prescribing information. Eli Lilly and Company; 2023. Accessed September 25, 2025 …
-
Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem
26 Sep 2025 12:58 GMT
… , 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the … factors which could impact expected benefits of the capacity expansion and … -biotechnology-ecosystem-302567273.html
SOURCE Eli Lilly and Company
-
Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines
26 Sep 2025 12:58 GMT
… Torrey Pines. First launched by Eli Lilly and Company in 2019 in the San … with biotech companies and scientists; benefits available to participants of Gateway …
-
Futures Flat Ahead Of Fed's Favorite Inflation Indicator
26 Sep 2025 13:12 GMT
US equity futures are flat as the market struggled for traction ahead of today's core PCE report and as investors ponder the Fed's next policy move following a raft of much stronger than expected US data. As of 8:00am, S&P futures are unchanged …
About
© 1995-2025